Financials
- Market Capitalization 10.78 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-45.32
売上高対価格比率
13.63
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 821 | TECH Bio-Techne Corp - Common Stock | 72.57 USD | +0.15% | -0.01% | +0.50% | +22.27% | 11.38 B USD | ||
| 849 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 55.42 USD | +1.13% | -3.73% | -16.66% | +5.86% | 10.73 B USD | ||
| 852 | IBRX ImmunityBio, Inc. - Common Stock | 10.11 USD | -3.81% | -2.79% | +28.14% | +324.79% | 10.71 B USD | ||
| 885 | PCVX Vaxcyte, Inc. - Common Stock | 70.68 USD | -0.98% | -4.43% | +17.72% | +67.09% | 10.52 B USD |